Latest Information Update: 18 Jun 1999
At a glance
- Originator SYNSORB Biotech
- Class Antibacterials
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Traveller's diarrhoea
Most Recent Events
- 18 Jun 1999 Discontinued-Preclinical for Traveller's diarrhoea in Canada (Unknown route)
- 14 Oct 1998 New profile
- 14 Oct 1998 Preclinical development for Traveller's diarrhoea in Canada (Unknown route)